ERBB2 and breast carcinoma: For example, luminal A (ER+ and/or PR+ but HER2−) breast cancers tend to develop bone metastasis with better survival compared to the visceral metastases associated with triple-negative breast cancers (TNBCs, which are ER−, PR−, and HER2−) [4].